HOME >> MEDICINE >> NEWS
Prostate cancer research may be faster with PSA endpoints

A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival. Researchers looking to speed up the process of clinical trials have suggested that these biomarkers could be used to measure treatment efficacy.

Currently, the U.S. Food and Drug Administration accepts only survival as an endpoint of measure. Survival as a primary endpoint was used in phase III studies of novel chemotherapeutic drugs for men with androgen-independent prostate.

Daniel P. Petrylak, M.D., associate professor of medicine at Columbia University College of Physicians & Surgeons and director of the genitourinary oncology program at NewYork-Presbyterian/Columbia, together with his research team, retrospectively analyzed results of 551 men with prostate cancer treated in the Southwest Oncology Group Protocol S9916. By reviewing the clinical trial, it was noted that there were several different changes in PSA levels, which could possibly serve as surrogate endpoints for survival.

The authors observed that the risk of death, in men whose serum PSA levels declined by at least 30 percent in the first three months of treatment, was reduced more than 50 percent. Findings are published in the Journal of the National Cancer Institute (April 19, 2006 issue).

"The findings show that PSA levels can be a reliable endpoint measure of prostate cancer treatment efficacy," said Dr. Petrylak, lead investigator. "However, this and other candidate surrogate endpoints must be validated in independent clinical trials of men with prostate cancer."

This study is a follow-up to a landmark phase III trial published in the New England Journal of Medicine (Oct. 7, 2004), by the same Columbia University Medical Center and NewYork-Presbyterian Hos
'"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
18-Apr-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... ... and clinical research networking-technology company founded by patient-survivors, and The Avoca Group, ... in the clinical trial execution process, today announced its mutual collaboration that ...
(Date:10/13/2018)... ... 13, 2018 , ... The National Fitness Foundation, the official ... Burley as its new Vice President of Partnerships & Marketing. , ... the mission of the President's Council by generating private sector investments and partnerships ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... medical clinic of all sizes and specialties. PrognoCIS , their Health IT ... for their patients. , Greater Houston Healthconnect (GHH), the region’s health information exchange ...
(Date:10/6/2018)... ... 2018 , ... Jose Rodriguez- Feliz M.D is a board–certified ... well known for their exclusivity, and luxurious lifestyle publication is privileged to present ... to the Haute Living network. , Haute Beauty consists of a prominent ...
(Date:10/5/2018)... ... 2018 , ... The Congress of Neurological Surgeons is pleased ... which currently includes 2-D and 3-D videos. Surgical Theater and NEUROSURGERY® Publications will ... number of surgical videos submitted to the journal will be invited to be ...
Breaking Medicine News(10 mins):
(Date:10/5/2018)... MCLEAN, Va. (PRWEB) , ... October 05, 2018 ... ... pleased to announce that Lissa Goldenstein has been named Chair-Elect of the Board ... the association’s strategic initiatives. RESOLVE is dedicated to ensuring that all people challenged ...
(Date:10/3/2018)... ... 2018 , ... Friends of Sheba Medical Center, Tel HaShomer and ... on Sunday evening, October 14th, which will celebrate 70 years of saving lives at ... treated members of the Israel Defense Forces (IDF) and civilians wounded during the War ...
(Date:10/3/2018)... ... October 03, 2018 , ... Arizona Arthritis & Rheumatology ... TSI Healthcare, a national leader in the sales and support of ... selected to be the sole software and support provider for Arizona Arthritis & ...
Breaking Medicine Technology:
Cached News: